Hydroxyurea induces de novo copy number variants in human cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 42, 2011, Pages 17360-17365

  Arlt, Martin F ^a   Ozdemir, Alev Cagla ^a   Birkeland, Shanda R ^a   Wilson, Thomas E ^a   Glover, Thomas W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ARTICLE; CELL CULTURE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; COPY NUMBER VARIATION; FIBROBLAST; GENE INSERTION; GENE REPLICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN GENOME; LOW DRUG DOSE; PRIORITY JOURNAL;

ANTISICKLING AGENTS; APHIDICOLIN; BASE SEQUENCE; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 3; DNA BREAKS; DNA COPY NUMBER VARIATIONS; DNA REPLICATION; ENZYME INHIBITORS; HUMANS; HYDROXYUREA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBONUCLEOTIDE REDUCTASES;

EID: 80054794827     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109272108     Document Type: Article

References (58)

1. Iafrate AJ, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36:949-951. (Pubitemid 39167488)
2. Redon R, et al. (2006) Global variation in copy number in the human genome. Nature 444:444-454. (Pubitemid 44809057)
3. Sebat J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305:525-528. (Pubitemid 38971344)
4. Sharp AJ, et al. (2005) Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77:78-88. (Pubitemid 40848038)
5. Conrad DF, et al.; Wellcome Trust Case Control Consortium (2010) Origins and functional impact of copy number variation in the human genome. Nature 464:704-712.
6. Mills RE, et al.; 1000 Genomes Project (2011) Mapping copy number variation by population-scale genome sequencing. Nature 470:59-65.
7. Korbel JO, et al. (2007) Paired-end mapping reveals extensive structural variation in the human genome. Science 318:420-426. (Pubitemid 47614521)
8. Durbin RM, et al.; 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061-1073.
9. Sudmant PH, et al.; 1000 Genomes Project (2010) Diversity of human copy number variation and multicopy genes. Science 330:641-646.
10. Girirajan S, Eichler EE (2010) Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19(R2):R176-R187.
11. Stankiewicz P, Lupski JR (2010) Structural variation in the human genome and its role in disease. Annu Rev Med 61:437-455.
12. Cook EH, Jr., Scherer SW (2008) Copy-number variations associated with neuropsychiatric conditions. Nature 455:919-923.
13. Kirov G, et al.; International Schizophrenia Consortium; Wellcome Trust Case Control Consortium (2009) Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 18:1497-1503.
14. Stankiewicz P, Beaudet AL (2007) Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 17:182-192. (Pubitemid 46843553)
15. Zhang F, Gu W, Hurles ME, Lupski JR (2009) Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 10:451-481.
16. Tam GW, Redon R, Carter NP, Grant SG (2009) The role of DNA copy number variation in schizophrenia. Biol Psychiatry 66:1005-1012.
17. Durkin SG, et al. (2008) Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci USA 105:246-251.
18. Arlt MF, et al. (2009) Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet 84:339-350.
19. Yarbro JW (1992) Mechanism of action of hydroxyurea. Semin Oncol 19(3, Suppl 9):1-10.
20. Atweh GF (2010) Hydroxyurea in sickle cell disease: What will it take to change practice? Am J Hematol 85:401-402.
21. Ware RE, Aygun B (2009) Advances in the use of hydroxyurea. Hematology Am Soc Hematol Educ Program 62-69.
22. Scott JP (2010) Hydroxurea and sickle cell disease: Its been a long, long time coming. Pediatr Blood Cancer 54:185-186.
23. Lou TF, Singh M, Mackie A, Li W, Pace BS (2009) Hydroxyurea generates nitric oxide in human erythroid cells: Mechanisms for gamma-globin gene activation. Exp Biol Med (Maywood) 234:1374-1382.
24. Charache S, et al.; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317-1322.
25. Kovacic P (2010) Hydroxyurea (therapeutics and mechanism): Metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications. Med Hypotheses 76:24-31.
26. Zimmerman SA, et al. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 103:2039-2045. (Pubitemid 38326218)
27. Flanagan JM, et al. (2010) Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res 698:38-42.
28. Kresse SH, et al. (2009) LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 48:679-693.
29. Yen CC, et al. (2009) Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 35:775-788.
30. Pasic I, et al. (2010) Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 70:160-171.
31. Bignell GR, et al. (2010) Signatures of mutation and selection in the cancer genome. Nature 463:893-898.
32. Elia J, et al. (2010) Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15:637-646.
33. Glessner JT, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569-573.
34. Mefford HC, et al. (2010) Genome-wide copy number variation in epilepsy: Novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 6:e1000962.
35. Ried K, et al. (2000) Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663. (Pubitemid 30427002)
36. Mrasek K, et al. (2010) Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int J Oncol 36:929-940.
37. Lee JA, Carvalho CM, Lupski JR (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235-1247. (Pubitemid 350297419)
38. Vissers LE, et al. (2009) Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture. Hum Mol Genet 18:3579-3593.
39. White SJ, et al. (2006) Duplications in the DMD gene. Hum Mutat 27:938-945. (Pubitemid 44336944)
40. Inoue K, et al. (2002) Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71:838-853. (Pubitemid 135750516)
41. Campbell PJ, et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722-729. (Pubitemid 351748860)
42. Conrad DF, et al. (2010) Mutation spectrum revealed by breakpoint sequencing of human germline CNVs. Nat Genet 42:385-391.
43. Arlt MF, et al. (2011) Comparison of constitutional and replication stress-induced genome structural variation by SNP array and mate-pair sequencing. Genetics 187:675-683.
44. Hastings PJ, Ira G, Lupski JR (2009) A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327.
45. Fiorenza MT, Bevilacqua A, Bevilacqua S, Mangia F (2001) Growing dictyate oocytes, but not early preimplantation embryos, of the mouse display high levels of DNA homologous recombination by single-strand annealing and lack DNA nonhomologous end joining. Dev Biol 233:214-224. (Pubitemid 32411306)
46. Kehrer-Sawatzki H, et al. (2004) High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75:410-423. (Pubitemid 39095817)
47. White SJ, den Dunnen JT (2006) Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 115:240-246. (Pubitemid 44832026)
48. Bruder CE, et al. (2008) Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82:763-771.
49. Piotrowski A, et al. (2008) Somatic mosaicism for copy number variation in differentiated human tissues. Hum Mutat 29:1118-1124.
50. Mkrtchyan H, et al. (2010) Early embryonic chromosome instability results in stable mosaic pattern in human tissues. PLoS ONE 5:e9591.
51. Anglana M, Apiou F, Bensimon A, Debatisse M (2003) Dynamics of DNA replication in mammalian somatic cells: Nucleotide pool modulates origin choice and interorigin spacing. Cell 114:385-394. (Pubitemid 36962936)
52. Courbet S, et al. (2008) Replication fork movement sets chromatin loop size and origin choice in mammalian cells. Nature 455:557-560.
53. Ge XQ, Jackson DA, Blow JJ (2007) Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev 21:3331-3341. (Pubitemid 350277759)
54. Karnani N, Dutta A (2011) The effect of the intra-S-phase checkpoint on origins of replication in human cells. Genes Dev 25:621-633.
55. Letessier A, et al. (2011) Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470:120-123.
56. Steinberg MH, et al.; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol 85:403-408.
57. Krishnamoorthy K, Thomson J (2004) A more powerful test for comparing two Poisson means. J Statist Plann Inference 119:23-35. (Pubitemid 37378881)
58. Kent WJ, et al. (2002) The human genome browser at UCSC. Genome Res 12:996-1006.